Analyst Ratings for BioCryst Pharma (BCRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2010 | Rodman & Renshaw | N/A | Upgrade | Market Outperform (N/A) |
N/A (N/A) |
4.82 (2.52) |
-47.72% | Details |
| 9/23/2010 | BofA/Merrill Lynch | N/A | Downgrade | Underperform (N/A) |
N/A (N/A) |
5.14 (2.52) |
-50.97% | Details |
